In order to investigate the breast cancer prediction problem on the aging population with the grades of DCIS, we conduct a tree augmented naive Bayesian network experiment trained and tested on a large clinical dataset including consecutive diagnostic mammography examinations, consequent biopsy outcomes and related cancer registry records in the population of women across all ages. Our tasks are to classify the conventional "Benign vs. Malignant" and the new "Benign/LG vs. IntG/HG/Invasive" based on mammography examination features and patient demographic information, specifically to predict the probability of malignancy, for the biopsy threshold setting and the biopsy decision making. The aggregated results of our ten-fold cross validation method recommend a biopsy threshold higher than 2% for the aging population. The Receiver Operating Characteristic curves and the Precision-Recall curves by aggregating the ten-fold cross validation results are interesting.
Introduction
The practice of mammography in aging populations successfully diagnoses breast diseases including invasive cancers at an earlier stage. [1] [2] However, the efficacy of mammography in older age groups can be affected substantially by inherent problems such as false-positive [3] [4] and over-diagnosis. 5 The false-positive problem leads to the problem of the high rate of breast biopsy: in the population of U.S. women older than 65 there are 140,000 breast biopsies cases per year, 6-7 75% of which turn out to be benign findings. Note that the procedure of breast biopsy is the most expensive component of breast cancer diagnosis. 8 These years the problem of the high rate of breast biopsy becomes more and more urgent: there are currently 21,784,000
women over age 65 and the first of the baby boom generation born in the year 1946 has been aged over 65 since the year 2011; it is also projected that the number of women over age 65 will double and the number of women over age 85 will increase fivefold from the year 2000 to the year 2050. 9 Another urgent problem emerges from the increasing rate of DCIS (ductal carcinoma in situ)
which is a non-obligate precursor to subsequent invasive breast cancer. [10] [11] DCIS, on one
hand, typically appears as microcalcifications on mammography, whereas microcalcifications could be related to benign conditions including fibrocystic changes, a fibroadenoma, or fat necrosis. 12 The microcalcifications are often pursued with biopsy for diagnosis, which leads to a low positive predictive value of biopsy. As a result, the 2009 National Institutes of Health (NIH) consensus conference on DCIS urges the development of methodologies to more accurately identify subsets of women who might not need the treatment for DCIS 13 and whose risk of progression could be low enough to employ watchful waiting (mammographic evaluation at short term intervals) rather than breast biopsy.
on DCIS highlighted the need for data and tools to improve management decisions. 13, [24] [25] The results of this conference were summarized as a "call to action" urging investigators to redouble efforts to determine optimal diagnosis and management of DCIS 24 and in turn prompted the Institute of Medicine to rank DCIS in the first quartile of topics to target comparative effectiveness research. 26 The literature has confirmed that the patient demographic risk factors and the mammographic findings as described by radiologists according to the standardized lexicon, the Breast Imaging
Reporting and Data System (BI-RADS) for mammogram feature distinctions and terminology, can predict the histology of breast cancer. [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] In order to investigate the breast cancer prediction problem on the aging population (the population of women over age 65) with the grades of DCIS, we conduct a tree augmented naive Bayesian network experiment trained and tested on a large clinical dataset including consecutive diagnostic mammography examinations, consequent biopsy outcomes and related cancer registry records in the population of women across all ages. The tasks of our experiment are to classify both the conventional task "Benign probabilities for the biopsy threshold setting and the biopsy decision making, the new task "B1 vs. M1" can help investigate the breast cancer prediction with respect to the grades of DCIS.
Methodology
In general, a Bayesian network represents variables as "nodes", which are data structures that contain an enumeration of possible values called "states" and store probabilities associated with each state, and conditional probabilities as "edges". A naive Bayes model assumes that given the class variable, the value ("state") of a particular feature variable is unrelated to the presence or absence of any other feature variable. Therefore in a naive Bayes model, the class variable is the "root node" and the directed arcs encode dependence relationships from the root node to the feature nodes. An important algorithm for naive Bayes model learning is to learn a tree structure to augment the edges of the naive Bayes network so as to produce a "tree augmented naive Bayesian network". 39 Specifically, the algorithm firstly computes for each pair of feature variables the mutual information functions as the weights, secondly finds the maximum weight spanning tree and assign edge directions, and finally attaches the tree structure to the naive Bayes model to construct a tree augmented naive Bayesian network. 
Experiment
We conduct experiment on a large clinical dataset combined by the University of Wisconsin- For the experiment, we model the demographic risk factors and the mammogram features as feature nodes and the result of the biopsy outcome and/or the cancer registry as root node, follow the tree augmented naive Bayesian network algorithm to learn the probabilities and the structure from training datasets, and predict the malignancy probabilities on testing datasets. Table 1 To label the biopsy outcome for the class variable, we used the most malignant result (Invasive > DCIS) and highest grade (HG > IntG > LG) at either core biopsy or subsequent surgery during the episode of care for analysis. The "episode of care" is defined as the duration of the process to definitively determine a breast diagnosis, including a core biopsy and subsequent diagnosis.
A single diagnosis may entail more than one biopsy to determine the extent of disease or to confirm a benign diagnosis. This episode of care may entail multiple biopsies over an interval of time. For our purposes, we define an episode of care as 6 months. If 2 biopsies were performed in the same breast within 6 months of each other, we considered them as in the same episode.
As the first step of the experiment, we prepare datasets for ten-fold cross validation: firstly randomly split the cases in each age group into ten equal-sized sets, each of which contains one-tenth of the benign findings, one-tenth of the invasive cancer findings and one-tenth of each of the grades of DCIS findings in that age group, along with the requirement that all records of the same patient be in the same set; secondly aggregate them into ten equal-sized folds of the whole population across all ages; and finally make ten pairs of training datasets and respective testing datasets. By using ten-fold cross validation, it is guaranteed that the cases used to train the model are never used to test the model. The second step is the implementation of the tree augmented naive Bayes algorithm. We use Weka (Waikato Environment for Knowledge Analysis) 40 for the training and testing of the tree augmented naive Bayesian network on the ten pairs of training datasets and respective testing datasets.
Finally, from the output prediction files given by Weka in the implementation of the tree augmented naive Bayes algorithm for the training and testing of the tree augmented naive
Bayesian network on the ten pairs of training datasets and respective testing datasets, we collect and aggregate the predicted malignancy probabilities on all the ten testing datasets. In order to estimate the predictive performance of the tree augmented naive Bayesian network methodology in test, following the convention of the literature, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] we construct the Receiver Operating Characteristic (ROC) curve and the Precision-Recall (PR) curve. The AUC which measures the area under the ROC curve is calculated. The AUCPR which measures the area under the PR curve is also meaningful [41] [42] [43] and is calculated as well.
Result
For the threshold analysis, Table 2 and Table 3 make snapshots of the confusion matrix results at typical thresholds in the whole population and in the aging population, respectively for the conventional task "B vs. M" and the new task "B1 vs. M1". From the tables we can see there are always actual malignancy cases with low malignancy probabilities predicted by the tree augmented naive Bayesian network methodology, both in the whole population and in the aging population. In fact, our EXCEL spreadsheet also shows not a few non-malignancy cases with high malignancy probabilities predicted by the methodology. But considering the number of the cases in the dataset, from a probabilistic perspective, we conclude the results are acceptable.
For the task "B vs. M", if we set the breast biopsy threshold to be 1%, no malignancy case will be missed and 22 non-malignancy cases will avoid breast biopsies. Thus 1% is the "critical threshold" and for the task "B1 vs. M1" it will save 41 non-malignancy biopsies. However, any threshold above 1% means there will be a tradeoff between avoided non-malignancy biopsies and missed malignancy biopsies. For both tasks, the conventional threshold of 2% in the whole population seems convincing, in spite of the one missed invasive aging case. In the aging population, a threshold higher than 2% would be acceptable, due to the fact that if the threshold is lifted from 2% to 7%, the number of avoided non-malignancy biopsies would rise sharply while the number of missed malignancy biopsies would rise very slowly. 
Summary
One weakness of this experiment is that we aggregate the predicted malignancy probabilities on all the ten testing datasets to produce the threshold analysis and the ROC curve. This procedure is based on the assumption that the trainings of the tree augmented naive Bayesian network on the ten training datasets are the same. Although all the trainings follow the tree augmented naive Bayes algorithm, the differences among the ten training datasets which stem from the variance of data source, lead to different tree augmented naive Bayesian network structures and probabilities.
Another weakness is that we make threshold analysis in the aging population using the tree augmented naive Bayesian networks trained by the cases across all ages. A more solid tree augmented naive Bayesian network experiment in the aging population should use only aging cases (women over age 65) for training and testing.
In sum, we conduct a tree augmented naive 
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